Skip to content

Magnesium infiltraion for mastectomy

Magnesium Sulphate infiltration for postoperative analgesia following mastectomy. A randomized controlled trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201802003034110
Enrollment
105
Registered
2018-01-31
Start date
2017-01-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Surgery postoperative pain management following mastectomy

Interventions

Group B
Group C

Sponsors

anesthesia department
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: -Society of Anesthesiologists physical status I and II females. -scheduled for unilateral MRM for breast cancer. -aged 30-65 years,

Exclusion criteria

Exclusion criteria: -Patients with known allergy to bupivacaine or magnesium. -History of chronic analgesic drug use. -On treatment with antidepressants, antiepileptics, sedatives or hypnotics for any reason. -Patients receiving chemotherapy or radiotherapy before surgery. -Presence of active malignancy elsewhere were also excluded.

Design outcomes

Primary

MeasureTime frame
assess acute postoperative pain at rest and during arm movement

Secondary

MeasureTime frame
quality of analgesia based on time to first demand for rescue analgesia, number of analgesic demands, 24h cumulative analgesic consumption, nausea and vomiting, wound hematoma or any complication during the 24 hour observation period.

Countries

Egypt

Contacts

Public ContactWegdan Ali

Lecturer of Anesthesiology

wegdan21122000@yahoo.com+20 01002522558

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026